While we did not investigate the molecular differences between the different vascular phenotypes, our findings are consistent with a report by Baruah et al., in which strong VEGF expression was seen in tumor and stromal cells in p16-negative tumors, while VEGF expression in p16+ tumors was restricted primarily to the stroma [23]. The gene discussed is CDKN2A; the disease is neoplasm.